Replies to post #141583 on Cytodyn Inc (CYDY)

[cowtown jay]

I don't recall seeing CYDY's endpoint as being dependent on the patients' ventilation status, whereas for HGEN, "...the primary endpoint of the trial has been changed to ventilator-free survival through day 28..." However, I want to see both products validated, and I think CYDY might have a bigger bang for the buck if approved. There will be a lot more retail reaction here, if that happens.